153. A patient is receiving an investigational chemotherapy agent. The nurse’s priority in this situation is to:

  • Monitor for expected common side effects only.
  • Strictly adhere to the research protocol and monitor for all potential adverse effects.
  • Allow the patient to self-administer the drug.
  • Disregard patient complaints not listed as common side effects.
Facebook
WhatsApp

You May Like etea medical mcqs

Comment

Scroll to Top